1. Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex

   • Àlex Rovira
   • María Luz Ruiz-Falcó
   • Josefina Vicente

   Topic Review 27 April 2014 Pages: 205 - 223

   

2. Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors

   • Nardin Samuel
   • Marc Remke
   • David Malkin

   Topic Review 26 April 2014 Pages: 225 - 238

3. Prognostic utility of gene therapy with herpes simplex virus thymidine kinase for patients with high-grade malignant gliomas: a systematic review and meta analysis

   • Fei Zhao
   • Jinhui Tian
   • Kehu Yang

   Topic Review 23 April 2014 Pages: 239 - 246

   

4. Interactions among mitochondrial proteins altered in glioblastoma

   • Ruth F. Deighton
   • Thierry Le Bihan
   • James McCulloch

   Laboratory Investigation Open access 13 April 2014 Pages: 247 - 256

   

5. Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme

   • Wen-Tsong Hsieh
   • Wei-Lan Yeh
   • Dah-Yuu Lu

   Laboratory Investigation 23 April 2014 Pages: 257 - 269

   

6. MGMT promoter methylation status in clival chordoma

   • Gianluca Marucci
   • Luca Morandi
   • Maria Pia Foschini

   Laboratory Investigation 26 April 2014 Pages: 271 - 276

   

7. Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis

   • Susanne Grube
   • Pedro Dünisch
   • Christian Ewald

   Laboratory Investigation 01 May 2014 Pages: 277 - 287

   

8. Karyopherin a2 and chromosome region maintenance protein 1 expression in meningiomas: novel biomarkers for recurrence and malignant progression

   • Konstantinos Gousias
   • Pitt Niehusmann
   • Matthias Simon

   Clinical Study 25 March 2014 Pages: 289 - 296

   

9. Reproductive factors and risk of primary brain tumors in women

   • Gabriella M. Anic
   • Melissa H. Madden
   • Kathleen M. Egan

   Clinical Study 04 April 2014 Pages: 297 - 304

10. Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood

    • Maura Massimino
    • Veronica Biassoni
    • Lorenza Gandola

    Clinical Study 03 April 2014 Pages: 305 - 312

    

11. Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial

    • Wenyin Shi
    • Yaacov Richard Lawrence
    • Adam P. Dicker

    Clinical Study 13 April 2014 Pages: 313 - 319

    

12. Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients

    • Thomas Hundsberger
    • Michaela Tonder
    • Michael Weller

    Clinical Study 16 April 2014 Pages: 321 - 328

    

13. Whole brain reirradiation and concurrent temozolomide in patients with brain metastases

    • Giuseppe Minniti
    • Claudia Scaringi
    • Riccardo Maurizi Enrici

    Clinical Study 10 April 2014 Pages: 329 - 334

    

14. A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC)

    • Marc C. Chamberlain
    • Sean Grimm
    • Brain Tumor Investigational Consortium (BTIC)

    Clinical Study 17 April 2014 Pages: 335 - 343

    

15. Intracranial ganglioglioma WHO I: results in a series of eight patients treated with stereotactic interstitial brachytherapy

    • Faycal El Majdoub
    • Essam Rezk
    • Mohammad Maarouf

    Clinical Study 27 April 2014 Pages: 345 - 350

    

16. Application of diffusion-weighted magnetic resonance imaging to predict the intracranial metastatic tumor response to gamma knife radiosurgery

    • Cheng-Chia Lee
    • Max Wintermark
    • Jason P. Sheehan

    Clinical Study 24 April 2014 Pages: 351 - 361

    

17. Yield and utility of routine postoperative imaging after resection of brain metastases

    • Ronald J. Benveniste
    • Nicholas Ferraro
    • Asterios Tsimpas

    Clinical Study 16 April 2014 Pages: 363 - 367

18. Decreased expression of LASS2 is associated with worse prognosis in meningiomas

    • Rong-Hu Ke
    • Yin Wang
    • Ji Xiong

    Clinical Study 17 April 2014 Pages: 369 - 376

    

19. IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy

    • Giuseppe Minniti
    • Claudia Scaringi
    • Riccardo Maurizi Enrici

    Clinical Study 20 April 2014 Pages: 377 - 383

    

20. Weight of epilepsy in brain tumor patients

    • Marta Maschio
    • Francesca Sperati
    • Tonino Cantelmi

    Clinical Study 01 May 2014 Pages: 385 - 393

21. Pediatric posterior fossa ganglioglioma: unique MRI features and correlation with BRAF V600E mutation status

    • Aaron J. Lindsay
    • Sarah Z. Rush
    • Laura Z. Fenton

    Clinical Study 03 May 2014 Pages: 395 - 404

    

22. Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing

    • Betty Y. S. Kim
    • Wen Jiang
    • Ian E. McCutcheon

    Clinical Study 29 April 2014 Pages: 405 - 412

    

23. Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial

    • Olgun Elicin
    • Ebrar Inac
    • Omer Erol Uzel

    Clinical Study 26 March 2014 Pages: 413 - 419

    

24. Erratum to: Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial

    • Olgun Elicin
    • Ebrar Inac
    • Omer Erol Uzel

    Erratum 11 April 2014 Pages: 421 - 421

25. Should the subventricular zone be part of the “rad” zone?

    • Benjamin W. Corn
    • Jeffrey Raizer
    • Andrew A. Kanner

    Editorial 23 May 2014 Pages: 423 - 424

26. ROS1 translocations and amplifications in lung cancer brain metastases

    • Matthias Preusser
    • Berthold Streubel
    • Peter Birner

    Letter to the Editor 24 April 2014 Pages: 425 - 426